openPR Logo
Press release

Colon Cancer Market Plying for Significant Growth During 2015 - 2021

02-27-2018 12:40 PM CET | Health & Medicine

Press release from: Persistence Market Research

Colon Cancer Market Plying for Significant Growth During 2015 -

Colon cancer is the cancer of large intestine which form the lower part of the digestive system. The disease usually begins with a small, benign clusters of cells known as adenomatous polyps. If left untreated, these polyps may result into colon cancer. Therefore, regular screening for polyps through colonoscopy in order to prevent it transforming to colon cancer is recommended. Change in bowel habits or blood in stool are the major symptoms of colon cancer.

Attributable epidemiological factors can be precancerous growth in the colon or genetic mutation. The American Society of Clinical Oncology (ASCO) recommends patients affected with colon cancer, for testing of genetic mutation in the KRAS gene which accounts for about 30% to 40% of colon tumors.

Request Sample Report@ https://www.persistencemarketresearch.com/samples/5423

There are three primary recommended therapies for treating colon cancer – surgery, chemotherapy and radiation. Surgical procedures such as colonoscopy, endoscopic mucosal resection, colectomy and laparoscopy are preferred in early-stage and invasive colon cancer treatment therapy. Besides, chemotherapy involves administration of drugs that destroy cancer cells, usually recommended after the surgery to reduce the risk of recurrence.

In addition, targeted drugs such as bevacizumab (Avastin), cetuximab (Erbitux), panitumumab (Vectibix) and regorafenib (Stivarga) are administered to patients with advanced colon cancer. Radiation therapy utilizes powerful X-ray radiations to kill the cancer cells left after surgery, shrink large tumors before the surgery or relieve symptoms of colon cancer. Usually combined with chemotherapy, radiation therapy aids in reducing the risk of recurrence.

Download and View Report TOC, Figures and Tables @ https://www.persistencemarketresearch.com/toc/5423

According to the Colon Cancer Alliance, colon cancer is the third most commonly diagnosed and second leading cause of cancer in the U.S. Rising incidences of colon cancer and high pricing of products have attracted pharmaceutical companies to develop and market new products. Healthcare practitioners are now cautioned with the cost-benefit ratio of colon cancer drugs owing to large presence and high pricing of products in this market. Extensive research and development in this field is expected to provide better and more effective medications in the future.

Some of the key players contributing to this market include Bedford Laboratories, Sanofi Aventis, Bayer AG, GlaxoSmithKline plc and Teva Pharmaceutical Industries Ltd.

Request Report Methodology @ https://www.persistencemarketresearch.com/methodology/5423

Key geographies evaluated in this report are:

North America, U.S, Canada, Europe, France, Germany, Italy, Spain, and the UK, Eastern Europe, CIS, APAC, China, India, Japan, Australia, Others, Latin America, Argentina, Brazil, Others,,Key features of this report,, Drivers, restraints, and challenges shaping the Colon Cancer market dynamics, Latest innovations and key events in the industry, Analysis of business strategies of the top players, Colon Cancer market estimates and forecasts(2015 -2021)

About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Colon Cancer Market Plying for Significant Growth During 2015 - 2021 here

News-ID: 959532 • Views:

More Releases from Persistence Market Research

Asparagus Market Growth Driven by Health Trends to Reach US$33.8 Bn by 2030 at 5.2% CAGR
Asparagus Market Growth Driven by Health Trends to Reach US$33.8 Bn by 2030 at 5 …
The global asparagus market is forecast to expand at a steady CAGR of 5.2%, increasing from a value of US$23.7 billion in 2023 to US$33.8 billion by the end of 2030. This growth trajectory is underpinned by the rising global demand for nutrient-rich vegetables and the expanding application of asparagus in culinary and functional food products. The growing health-conscious consumer base, combined with an increasing preference for plant-based and low-calorie
Flat Glass Market Valued at US$ 213.0 Billion in 2025, Projected to Reach US$ 326.7 Billion by 2032 - Persistence Market Research
Flat Glass Market Valued at US$ 213.0 Billion in 2025, Projected to Reach US$ 32 …
The global flat glass market has become one of the fastest-growing sectors in the materials industry, driven by its wide range of applications across construction, automotive, and renewable energy sectors. Flat glass, also known as sheet glass, is produced in large, flat sheets and can be processed further into laminated, tempered, or coated forms for enhanced performance. Its versatility, transparency, and strength make it an essential material for modern architectural
Essential Oils Market Value to Reach US$39.1 Bn by 2031 Driven by Rising Demand for Natural Products
Essential Oils Market Value to Reach US$39.1 Bn by 2031 Driven by Rising Demand …
The global essential oils market is witnessing robust expansion, with the market size valued at US$20.6 billion in 2024 and projected to reach US$39.1 billion by 2031. This growth represents a significant compound annual growth rate (CAGR) of 7.7% during the forecast period from 2024 to 2031. The increasing consumer inclination toward natural and organic products, coupled with the rising adoption of aromatherapy and natural ingredients across personal care, food
Natural Food Preservatives Market Value to Reach US$1.2 Bn by 2031 Driven by Clean Label Demand
Natural Food Preservatives Market Value to Reach US$1.2 Bn by 2031 Driven by Cle …
The global natural food preservatives market continues to gain momentum as consumers and food manufacturers increasingly shift toward cleaner, more transparent ingredient formulations. The market was valued at US$0.9 billion in 2024 and is projected to reach US$1.2 billion by 2031, expanding at a CAGR of 3.9% during the forecast period from 2024 to 2031. This steady growth trajectory underscores the growing importance of natural ingredients in ensuring food safety,

All 5 Releases


More Releases for Colon

Colon Broom Real Reviews - Does Colon Broom Work for Weight Loss?
Colon Broom is a regular fiber-based supplement that promotes healthy digestion and gut health by utilizing natural components. The product is aimed at people who are tired of slow digestion, bloating, and irregularity. However, rather than a harsh cleanse or a fast detox, this product takes a gentler, more sustainable approach: fiber. The ingredients of Colon Broom are basic but effective, with psyllium husk being the star.
Colon Cleansing Supplements Market Overview 2022 to 2030, Future Trends and Fore …
Colon Cleansing Supplements Market 2022 Global Industry research report provide detailed analysis of growth factors of the global industry as well as it gives analysis of market share, latest trends, size and forecast until 2030. The Colon Cleansing Supplements industry report has studied key opportunities in the market and influencing factor which is useful to the business. The global Colon Cleansing Supplements market is expected to register a CAGR of 3.2%
Global Colon Cleanse Market Analysis (2020-2025)
Global Info Research offers a latest published report on Colon Cleanse Analysis and Forecast 2020-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Colon Cleanse Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/reports/266412/colon-cleanse Market
Global Colon Cleansing Supplements Market: Key Players to Tap Emerging Markets i …
LOS ANGELES, United States: QY Research as of late produced a research report titled, “Global Colon Cleansing Supplements Market Research Report 2020". The research report speak about the potential development openings that exist in the worldwide market. The report is broken down on the basis of research procedures procured from historical and forecast information. The global Colon Cleansing Supplements market is relied upon to develop generously and flourish as far
Colon Cleansing Supplements Market- Key Vendors ( Vita Balance, PRIVATELABELSUPP …
Global Colon Cleansing Supplements Market: Snapshot Colon cleansing is essential if one needs to lose a few pounds of weight, solve acne problems, or improve their digestive system. There are several supplements are now available that adequately match the requirements and according to the findings of this study, the demand for them would be expanding profitably over the course of 2017 to 2027, gaining traction from increased awareness levels among the
Colon Cancer Pipeline Therapeutics Review H1 2017
Colon Cancer Pipeline Drugs Review H1 2017 provides an overview of the Colon Cancer therapeutics (Oncology) pipeline landscape. Colon cancer is cancer that starts in the large intestine (colon). There is no single cause of colon cancer. Nearly all colon cancers begin as noncancerous (benign) polyps, which slowly develop into cancer. For More on Colon Cancer Pipeline Review H1 2017 Report Inquire @ https://tinyurl.com/Colon-Cancer-Therapeutic . Report Description: Pharmaceutical guide Colon Cancer - Pipeline